Advertisement
open access | |
logout
Medical Conferences
Conference Reports
Conference Proceedings
Specialties
Cardiology
Dermatology
Endocrinology
Gastroenterology
Haematology
Nephrology
Neurology
Oncology
Psychiatry
Pulmonology
Rheumatology
Urology
Multimedia
Podcast channel
Video channel
About
2024 Medicom Conference Planning
About Conference Proceedings
Webinar
Home
>
Oncology
>
BCC 2019
BCC 2019
St. Gallen International Breast Cancer Conference
20–23 March 2019,
Vienna, Austria
Read the full Report (e-book)
Table of Contents
Colophon
Table of Contents
Featured articles
Letter from the Editor
Editor
Dr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Esch, Luxembourg
New Prognostic Biomarkers for Survival Breast Cancer
Presented By
Dr Jasmin Zeindler, University Hospital Basel, Switzerland
St. Gallen Consensus
History of the consensus meeting
Primary surgery: margins
Skin and nipple sparing surgery: still a matter of debate
Surgery of the axilla: indications decrease
DCIS: de-escalation of (adjuvant) therapy
Gene expression signatures
Neoadjuvant therapy and residual disease
Adjuvant chemotherapy after neoadjuvant chemotherapy? Going beyond EMA/FDA
Endocrine therapy in premenopausal patients
Endocrine therapy in postmenopausal patients: a graded approach
Adjuvant Her2-targeted therapy
Adjuvant therapy in triple-negative breast cancer
Bisphosphonates and denosumab
Germ-line mutations
Pregnancy after breast cancer
Life style
Special Lectures
Extrapolating data from clinical trials as we treat patients in real life
Presented By
Prof. Sharon Giordano, MD Anderson, Houston, USA
What is the clinical benefit of treatment of patients with early breast cancer?
Presented By
Prof. Ann Partridge, Dana-Farber Cancer Institute, Boston, USA
Adjuvant and neoadjuvant therapy: principles and practical considerations
Presented By
Prof. Eric Winer, Dana-Farber Cancer Institute, Boston, USA
Selected Posters
Discordance of biomarkers in multifocal and lymph node positive breast cancer
Presented By
Dr Marie Sundquist, Kalmar County Hospital, Sweden
New Prognostic Biomarkers for Survival Breast Cancer
Presented By
Dr Jasmin Zeindler, University Hospital Basel, Switzerland
Selection of patients for neoadjuvant chemotherapy treatment based on oncotype recurrence score in luminal breast cancer
Presented By
Dr Ariadna Gasol Cudos, Hospital Universitari Arnau de Vilanova de Lleida, Spain